Frontiers in Microbiology · 2019 · 163 citations · 41 references
Life SciencesPharmacologyPharmacotherapyInflammationMicrobial PhysiologyMicrobiome ResearchGut MicrobiomeGut MicrobiotaMetabolic InflammationMicrobiome FunctionBacteroides SpeciesCholesterol-lowering EffectsGut Microbiota CompositionGut Microbiota DysbiosisGut Microbiota EffectsInflammatory Response Genes
Dysbiosis of the gut microbiota is a contributing factor for obesity-related metabolic diseases such as hyperglycemia and hyperlipidemia. Pharmacotherapy for metabolic diseases involves the modulation of gut microbiota, which is suggested to be a potential therapeutic target. In this study, the modulation of gut microbiota by statins (cholesterol-lowering drugs: atorvastatin and rosuvastatin) was investigated in an aged mouse model of high-fat diet-induced obesity, and the association between gut microbiota and immune responses was described. Atorvastatin and rosuvastatin significantly increased the abundance of the genera Bacteroides, Butyricimonas, and Mucispirillum. Moreover, the abundance of these genera was correlated with the inflammatory response, including levels of IL-1β and TGFβ1 in the ileum. In addition, oral fecal microbiota transplantation with fecal material collected from rosuvastatin-treated mouse groups improved the hyperglycemia. From these results, the effect of statins on metabolic improvements could be explained by altered gut microbiota. Our findings suggest that the modulation of gut microbiota by statins has an important role in the therapeutic actions of these drugs.
41
Metagenomic biomarker discovery and explanation
Nicola Segata, Jacques Izard, Levi Waldron et al. · Genome biology · 2011 · 16.7K citations · Full text
Human gut microbes associated with obesity
Ruth E. Ley, Peter J. Turnbaugh, Samuel Klein et al. · Nature · 2006 · 8.8K citations
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Bo Isomaa, Peter Almgren, Björn Forsén et al. · Diabetes Care · 2001 · 4.8K citations
Medicine, Endocrinology, Diabetology +15